Biotech industry hopes for breakthrough from new Commission strategy
A biotechnology strategy for the EU, adopted by the Commission on 23 January, raises hopes for a new start for the European biotech industry, stalled for years by legislative obstacles. The paper, entitled Life Sciences and Biotechnology: A Strategy for Europe, warns that prejudice against biotechnology has cost Europe in terms of jobs, growth and prosperity.
A biotechnology strategy for the EU, adopted by the Commission on 23 January, raises hopes for a new start for the European biotech industry, stalled for years by legislative obstacles. The paper, entitled Life Sciences and Biotechnology: A Strategy for Europe, warns that prejudice against biotechnology has cost Europe in terms of jobs, growth and prosperity.
